Linagliptin impurity 16 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

N-Carbamoyl Linagliptin is a derivative of Linagliptin (L465900), a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.

Linagliptin impurity 16 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Linagliptin impurity 16 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Guangzhou CATO Research Chemicals Inc.	+86-020-81960175-617 +8615602392859	Intermediate@cato-chem.com	China	6335	58
S.Z. PhyStandard Bio-Tech. Co., Ltd.	0755-4000505016 13380397412	3001272453@qq.com	China	5160	50
ChemStrong Scientific Co.,Ltd	0755-0755-66853366 13670046396	sales@chem-strong.com	China	18157	56
Shandong Boluoda Biological Technology Co., Ltd.	0531-68652053	2310993908@qq.com	China	1991	58
Shanghai Kewel Chemical Co., Ltd.	021-64609169 18901607656	greensnown@163.com	China	9906	50
Lynnchem	86-(0)29-85992781 17792393971	info@lynnchem.com	China	4587	58
Hubei Yangxin Medical Technology Co., Ltd.	15374522761	3003392093@qq.com	China	8867	55
Novachemistry	44-20819178-90 02081917890	info@novachemistry.com	United Kingdom	4381	58
Shenzhen SUNGENING Bio-Medical Co., Ltd.	0755-28967200 13631290199	wxf@sungening.com	China	9581	60
XinYao(Shenzhen) Biological Technology Co., Ltd.	0755-89880280	3004662104@qq.com	China	1829	58

---

• Ligliptin Impurity CD10925
• Linagliptin Imp.CD10925
• Urea, N-[1-[7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-
• Linagliptin N-Aminocarbonyl Impurity
• Linagliptin Impurity 106
• 8-[(3R)-3-Aminocarbonylamino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione
• {1-[7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl]piperidin-3-yl}urea
• 1955514-80-3